1-(3-bromo-4-hydroxyphenethyl)-N-(3,5-dibromo-4-hydroxyphenethyl)-1H-1,2,3-triazole-4-carboxamide

ID: ALA3739616

Chembl Id: CHEMBL3739616

PubChem CID: 127039530

Max Phase: Preclinical

Molecular Formula: C19H17Br3N4O3

Molecular Weight: 589.08

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(NCCc1cc(Br)c(O)c(Br)c1)c1cn(CCc2ccc(O)c(Br)c2)nn1

Standard InChI:  InChI=1S/C19H17Br3N4O3/c20-13-7-11(1-2-17(13)27)4-6-26-10-16(24-25-26)19(29)23-5-3-12-8-14(21)18(28)15(22)9-12/h1-2,7-10,27-28H,3-6H2,(H,23,29)

Standard InChI Key:  GCVZXZIZUVRMQY-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3739616

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 589.08

Molecular Weight (Monoisotopic): 585.8851

AlogP: 4.19

#Rotatable Bonds: 7

Polar Surface Area: 100.27

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 6.75

CX Basic pKa: ┄

CX LogP: 5.21

CX LogD: 4.44

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.38

Np Likeness Score: -0.86

References

1. Andjouh S, Blache Y..  (2015)  Click-based synthesis of bromotyrosine alkaloid analogs as potential anti-biofilm leads for SAR studies.,  25  (24): [PMID:26564265] [10.1016/j.bmcl.2015.10.073]

Source

Source(1):

• Scientific Literature